MedPath

Maternal and neonatal effects of remifentanil in general anaesthesia for Caesarean delivery

Not Applicable
Conditions
Remifentanil.
Opioids and related analgesics
Registration Number
IRCT201102252963N2
Lead Sponsor
Shahid Sadoughi University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
80
Inclusion Criteria

women with American Society of Anesthesia (ASA) physical status I or II and singleton term pregnancies who are candidate for cesarean section that is not emergent
Exclusion criteria: Anaphylaxis reaction to the anesthetic drugs, excessive bleeding during the operation

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diastolic blood pressure. Timepoint: before of induction of general anesthesia,immediately after laryngoscopy and intubation, after incision of skin, after delivery of fetus. Method of measurement: NIBP monitoring.;Systolic blood pressures. Timepoint: before of induction of general anesthesia,immediately after laryngoscopy and intubation, after incision of skin, after delivery of fetus. Method of measurement: NIBP monitoring.;Mean arterial pressure. Timepoint: before of induction of general anesthesia,immediately after laryngoscopy and intubation, after incision of skin, after delivery of fetus. Method of measurement: NIBP monitoring.;Heart rate in mother. Timepoint: before of induction of general anesthesia,immediately after laryngoscopy and intubation, after incision of skin, after delivery of fetus. Method of measurement: EKG monitoring.
Secondary Outcome Measures
NameTimeMethod
APGAR score in the neonate. Timepoint: 1 and 5 minutes after birth. Method of measurement: APGAR score.;Umblical cord PH. Timepoint: After delivery. Method of measurement: blood gas analysis.
© Copyright 2025. All Rights Reserved by MedPath